2022 Trade Show Recaps

John Elliott, representing Carevive, shared valuable insights and takeaways from various industry conferences and events. In this recap, he highlighted key findings from the ASCO Quality Conference, American Society of Cancer Institute (ASCI) event, Community Cancer Association (CCA) conference, Oracle Cerner Health Conference, and JADPRO. John emphasized the importance of patient experience, implementation science, and the role of technology in addressing healthcare challenges. The industry’s focus on collaboration, equity, and multidisciplinary electronic patient-reported outcomes (ePROs) was also evident. Carevive’s presence as a thought leader in these events demonstrated their commitment to transforming oncology care and supporting healthcare professionals.

Key Themes and Takeaways:
The ASCO Quality Conference showcased the significance of ePROs, with Dr. Gabriel Roche from UAB leading conversations on their impact as a standard of care. The ASCI event celebrated Northwell Cancer Institute as the 106th site and emphasized health equity as a crucial focus. At the CCA conference, multidisciplinary ePROs emerged as a rising trend, extending beyond oncology to chronic diseases and other populations. The Oracle Cerner Health Conference emphasized the priority of patient experience and the need to bridge gaps in native EMR capabilities. Lastly, JADPRO highlighted the challenges faced by advanced practice nurses and the potential of technology to enhance their capabilities and alleviate staffing issues.

Recent Episodes

Denials are no longer a slow leak in the revenue cycle—they’re a fast-moving, rule-shifting game controlled by payers, and hospitals that don’t model denial patterns in real time end up budgeting around losses they could have prevented. PayerWatch’s four-digit, client-verified ROI in 2024 shows what happens when a hospital stops reacting claim by…

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

In “Fighting for Coverage,” a patient describes a double war: the physical fight to stay alive and the bureaucratic fight to prove to an insurer that her life is worth the cost. Her account spotlights a core tension in the U.S. system—coverage decisions are increasingly shaped by prior authorizations and desk-based reviewers who…